ELEVATE Study: Design

Opinion
Video

Hope S. Rugo, MD, FASCO, discusses how the phase 3 ELEVATE study evaluates the combination of elacestrant with abemaciclib in patients with ER+/HER2– advanced or MBC who have progressed on prior endocrine therapy.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
1 expert in this video
1 expert in this video
3 experts are featured in this series.
1 expert in this video
3 experts are featured in this series.
1 expert in this video
3 experts are featured in this series.
3 experts are featured in this series.